NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Viatris Inc.

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces an ...

The stock's fall snapped a three-day winning streak.

Shares of Viatris Inc. VTRS rose 2.92% to $9.52 Tuesday, on what proved to be an all-around rough trading session for the ...

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside ...

Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit growth in its commercial pharmaceuticals unit in the full year, benefiting ...

JOHANNESBURG (Reuters) -Aspen Pharmacare reported a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit growth from its commercial pharmaceuticals unit in ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. President Donald Trump’s first month in office has been dizzying for U.S ...

Viatris (NASDAQ:VTRS), a global healthcare company known for its broad portfolio of pharmaceutical products, released its fourth-quarter 2024 results on Feb. 27. Despite achieving substantial debt ...

PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48 ...